Target Validation Information
Target ID T37539
Target Name B-cell receptor CD22
Target Type
Successful
Drug Potency against Target Epratuzumab Drug Info Ki = 10 nM [553078]
References
Ref 553078Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(6):R204. doi: 10.1186/ar3179. Epub 2010 Nov 4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.